Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias

Clinica Chimica Acta

Volumn 266, Issue 1, 1997, Pages 63-74

  Clarke, Douglas J ^a   Moghrabi, Nabil ^a   Monaghan, Gemma ^a   Cassidy, Andrew ^a   Boxer, Maureen ^a   Hume, Robert ^a   Burchell, Brian ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bilirubin UDP glucuronosyltransferase; Crigler Naijar syndrome; Gilbert's syndrome; Mutations; UGT1 gene; Unconjugated hyperbilirubinaemia

Indexed keywords

GLUCURONOSYLTRANSFERASE; PHENOBARBITAL;

ALLELE; CONFERENCE PAPER; CRIGLER NAJJAR SYNDROME; ENZYME DEFICIENCY; EXON; GENETIC DISORDER; GILBERT DISEASE; HUMAN; HYPERBILIRUBINEMIA; MISSENSE MUTATION; MUTANT; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX;

CRIGLER-NAJJAR SYNDROME; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HETEROZYGOTE; HUMANS; VARIATION (GENETICS);

EID: 0030728222     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00167-8     Document Type: Conference Paper

References (42)

1. Roy Chowdhury J, Wolkoff A, Roy Chowdhury N, Arias IM. Hereditary jaundice and disorders of bilirubin metabolism. In: Scriver CR, Beaudet AI, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited diseases, 7th edition. New York: McGraw Hill, 1995;Chapter 67:2161-2208.
2. Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Hories T, Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-8.
3. Arias IM, Gartner LM, Cohen M, Ezzer JB, Levi J. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med 1969;47:395-409.
4. Sinaasappel M, Jansen PL. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis. Gastroenterology 1991;100:783-9.
5. Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 1994;303:233-40.
6. Ritter JK, Chen F, Sheen YY, Tran HM, Kimma S, Yeatman MT, Owens IS. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992;267:3257-61.
7. van Es HH, Bout A, Liu J, Anderson L, Duncan AM, Bosma P, Oude-Elferink R, Jansen PL, Roy Chowdhury J, Schurr E. Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. Cytogenet Cell Genet 1993;63:114-6.
8. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude ER, Roy Chowdhury J, Roy Chowdhury N, Jansen PL. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994;269:17960-4.
9. Ebner TE, Burchell B. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 family. Drug Metab Dispos 1993;21:50-5.
10. Green MD, Bishop WP, Tephly TR. Expressed human UGT1.4 Protein catalyses the formation of quaternary ammonium linked glucuronides. Drug Metab Dispos 1995;23:299-302.
11. Ritter JK, Yeatman MT, Kaiser C, Gridelli B, Owens ISA. Phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem 1993;268:23573-9.
12. Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Roy Chowdhury J, Roy Chowdhury N, Jansen PL, Oude ER. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 1994;94:2385-91.
13. Ciotti M, Yeatman MT, Sokol RJ, Owens IS. Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient. J Biol Chem 1995;270:3284-91.
14. Aono S, Yamada Y, Keino H, Sasaoka Y, Nakagawa T, Onishi S, Mimura S, Koiwai O, Sato H. A new type of defect in the gene for bilirubin uridine 5′-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I. Pediatr Res 1994;35:629-32.
15. Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, Trivin F, Roy Chowdhury N, Roy Chowdhury J, Munnich A, Odievre M. Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet 1994;94:693-7.
16. Ritter JK, Yeatman MT, Ferreira P, Owens IS. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J Clin Invest 1992;90:150-5.
17. Erps LT, Ritter JK, Hersh JH, Blossom D, Martin NC, Owens IS. Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest 1994;93:564-70.
18. Bosma PJ, Roy Chowdhury J, Huang TJ, Lahiri P, Elferink RP, Van EH, Lederstein M, Whitington PF, Jansen PL, Roy Chowdhury N. Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J 1992;6:2859-63.
19. Moghrabi N, Clarke DJ, Burchell B, Boxer M. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis. Am J Hum Genet 1993;53:722-9.
20. Bosma PJ, Roy Chowdhury N, Goldhoorn BG, Hofker MH, Oude ER, Jansen PL, Roy Chowdhury J. Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Hepatology 1992;15:941-7.
21. Ciotti M, Obaray R, Martin M, Owens IS. Identification of a 2-base mutation in the bilirubin UDP-glucuronosyltransferase gene at the UGT1 gene-complex locus in 2 unrelated Crigler-Najjar type-1 patients. FASEB J 1995;9:A1267.
22. Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP. A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett 1996;390:294-8.
23. Soeda Y, Yamamoto K, Adachi Y, Hori T, Aono S, Koiwai O, Sato H. Predicted homozygous mis-sense mutation in Gilbert's syndrome. Lancet 1995;346:1494.
24. Koiwai O, Nishizawa M, Hasada K, Aono S, Adachi Y, Mamiya N, Sato H. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet 1995;4:1183-6.
25. Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 1995;345:958-9.
26. Sato H, Adachi Y, Koiwai O. The genetic basis of Gilbert's syndrome. Lancet 1996;347:557-8.
27. Bosma P, Roy Chowdhury J, Jansen PH. Genetic inheritance of Gilbert's syndrome. Lancet 1995;346:314-5.
28. Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, Yazawa T, Sato H, Koiwai O. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 1993;197:1239-44.
29. Bosma PJ, Goldhoorn B, Oude ER, Sinaasappel M, Oostra BA, Jansen PL. A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform l causing Crigler-Najjar syndrome type II. Gastroenterology 1993;105:216-20.
30. Yamamoto K, Soeda Y, Adachi Y, Sato H, Fukano M, Koiwai O, Doida Y, Fujiyama Y, Bamba T. Genetic analysis of four patients with Crigler-Najjar syndrome type II. Gastroenterology 1996;110:A1364.
31. Moghrabi N, Clarke DJ, Boxer M, Burchell B. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics 1993;18:171-3.
32. Koiwai O, Aono S, Adachi Y, Kamisako T, Yasui Y, Nishizawa M, Sato H. Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait. Hum Mol Genet 1996;5:645-7.
33. Rubaltelli D, Ciotti M, Rubaltelli FF, Owens IS. Different missense mutations at the UGT1 gene-complex locus that generate pH-sensitive activity of the major bilirubin UDP-glucuronosyltransferase in Crigler-Najjar type-II patients. FASEB J 1995;9:A1267.
34. Lascelles PT, Donaldson D. Calorie restriction test. In: Lascelles PT, Donaldson D, editors. Diagnostic function tests in chemical pathology. Lancaster: Kluwer, 1989:24-25.
35. Ideo G, De Franchis R, Del Ninno E, Dioguardi N. Ethanol increases liver uridinediphosphate-glucuronosyltransferase. Experientia 1971;27:24-5.
36. Brierley CH, Senafi SB, Clarke D, Hsu M-H, Johnson EF, Burchell B. Regulation of the human bilirubin UDP-glucuronosyltransferase gene. Adv Enz Regul 1996;36:85-97.
37. Bosma PJ, Roy Chowdhury J, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-5.
38. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996;347:578-81.
39. Monaghan G, Foster B, Jurima-Romet M, Hume R, Burchell B. UGT1*1 genotyping in a Canadian Inuit population. Pharmacogenetics 1997;7:153-6.
40. Landaw SA, Drummond GS, Kappas A. Targeting of heme oxygenase inhibitors to the spleen markedly increases their ability to diminish bilirubin production. Pediatrics 1989;84:1091-6.
41. Kappas A, Drummond GS, Galbraith RA. Prolonged clinical use of a heme oxygenase inhibitor: hematological evidence for an inducible but reversible iron-deficiency state. Pediatrics 1993;91:537-9.
42. van der Veere CN, Sinaasappel M, McDonagh AF, Rosenthal P, Labrune P, Odievre M, Fevery J, Otte JB, McClean P, Burk G, Masakowski V, Sperl W, Mowat AP, Vergani GM, Heller K, Wilson JP, Shepherd R, Jansen PL. Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology 1996;24:311-5.